Cargando…
Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis: A Prospective Longitudinal Study
To determine the incidence of permanent visual loss (PVL) in giant cell arteritis (GCA) and the GCA relapse rate during glucocorticoid (GC) tapering. This prospective, longitudinal single secondary/tertiary rheumatology centre study was conducted between September 2011 and September 2014 in Slovenia...
Autores principales: | Hocevar, Alojzija, Rotar, Ziga, Jese, Rok, Semrl, Snezna Sodin, Pizem, Joze, Hawlina, Marko, Tomsic, Matija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998766/ https://www.ncbi.nlm.nih.gov/pubmed/27057850 http://dx.doi.org/10.1097/MD.0000000000003210 |
Ejemplares similares
-
COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia
por: Kramarič, Jelka, et al.
Publicado: (2022) -
From Active to Non-active Giant Cell Arteritis: Longitudinal Monitoring of Patients on Glucocorticoid Therapy in Combination With Leflunomide
por: Kuret, Tadeja, et al.
Publicado: (2022) -
Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study
por: Kramarič, Jelka, et al.
Publicado: (2022) -
The incidence of spondyloarthritis in Slovenia
por: Hočevar, Alojzija, et al.
Publicado: (2019) -
Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis
por: Kuret, Tadeja, et al.
Publicado: (2021)